Test my supply
+2 more ↓
61%
Finnrick rating
#264 of 301 ranked vendors
18 of 48 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Nuscience Peptides shows its clearest purity-focused signal in GHK-Cu and improving Tirzepatide/Semaglutide results, but the catalog remains uneven across batches. CJC-1295, Melanotan II, Ipamorelin, and Mazdutide carry repeated purity or fill misses; evidence is recent and fairly broad, though several weak signals are same-batch.

methodology →
vendor intelligence report
Vendor Intelligence Report: Nuscience Peptides

We investigated who actually operates Nuscience Peptides — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.

29 pages6 risk factors assessed12 Jun 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.90
89%
2
2
Tirzepatide
$15.00
74%
6
3
Retatrutide
$17.80
68%
8
4
Ipamorelin
$7.60
63%
2
5
Semaglutide
$13.98
62%
14
6
PT-141
$4.50
54%
2
7
Mazdutide
$20.90
53%
2
8
BPC-157
$7.00
50%
2
9
Melanotan II
$3.00
41%
7
10
CJC-1295
$11.00
23%
3
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%30 Apr 2025: 43%30 Apr 2025: 40%30 Apr 2025: 39%30 Apr 2025: 38%5 May 2025: 38%5 May 2025: 38%5 May 2025: 38%5 May 2025: 37%5 May 2025: 36%6 May 2025: 39%6 May 2025: 38%6 May 2025: 49%6 May 2025: 50%6 May 2025: 49%6 May 2025: 48%7 May 2025: 47%7 May 2025: 48%7 May 2025: 50%7 May 2025: 50%7 May 2025: 50%7 May 2025: 49%7 May 2025: 49%7 May 2025: 50%7 May 2025: 50%7 May 2025: 50%16 May 2025: 51%16 May 2025: 51%21 May 2025: 50%21 May 2025: 50%21 May 2025: 50%21 May 2025: 50%23 Jul 2025: 50%31 Aug 2025: 51%10 Sept 2025: 51%10 Sept 2025: 51%10 Sept 2025: 51%10 Sept 2025: 52%15 Jan 2026: 53%13 Feb 2026: 55%8 May 2026: 56%10 Aug 2026: current 61%43%53%61%Apr 25Aug 26
Test my supply
Nuscience Peptides test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
8 May 2026Pass
Melanotan II
lab nameView COA
13 Feb 2026Pass
Retatrutide
lab nameView COA
15 Jan 2026Pass
Tirzepatide
lab nameView COA
10 Sep 2025Pass
Semaglutide
lab nameView COA
10 Sep 2025Pass
Tirzepatide
lab nameView COA
10 Sep 2025Pass
Semaglutide
lab nameView COA
10 Sep 2025Pass
Tirzepatide
lab nameView COA
31 Aug 2025Fail
Tirzepatide
lab nameView COA
23 Jul 2025Pass
Retatrutide
lab nameView COA
21 May 2025Fail
Retatrutide
lab nameView COA
1-10 of 48

About Nuscience Peptides test results from Finnrick

Nuscience Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 10 peptides and 48 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Nuscience Peptides peptides in this dataset are Melanotan II (7 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 48 recent tests.

Corrections
No corrections.
Test my supply